The Greater Cannabis Company, Inc.
GCAN · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.04 | 0.06 | 0.03 |
| FCF Yield | -34.02% | -15.86% | -33.25% | -15.51% |
| EV / EBITDA | -4.60 | -5.37 | -2.39 | -5.70 |
| Quality | ||||
| ROIC | 38.22% | 76.31% | 427.69% | -214.42% |
| Gross Margin | 0.00% | 0.00% | 0.00% | -0.20% |
| Cash Conversion Ratio | 0.61 | 0.55 | 0.30 | 0.39 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% | 21.05% |
| Free Cash Flow Growth | -6.13% | 4.02% | 54.34% | 25.17% |
| Safety | ||||
| Net Debt / EBITDA | -2.47 | -1.55 | -1.00 | -0.81 |
| Interest Coverage | 0.00 | -13.45 | -1.44 | -1.20 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -444.86 | -113.99 | -337.60 |